(Q37813013)

23 August 2017

1 reference

title

TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions (English)

1 reference

23 August 2017

4

E Glatstein

1 reference

23 August 2017

C E Hill-Kayser

1

1 reference

23 August 2017

J P Plastaras

series ordinal

2

1 reference

23 August 2017

Z Tochner

series ordinal

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

29 November 2010

1 reference

Bone Marrow Transplantation

23 August 2017

published in

1 reference

23 August 2017

volume

46

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

475-484

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2010.280

23 August 2017

exact match

0 references

cites work

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Bone-marrow transplantation (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Autologous hematopoietic stem cell transplantation (AHSCT) as consolidation therapy for childhood acute myelogenous leukemia in 1st complete remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Fractionated total body irradiation and bone marrow transplantation in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Combination approaches to immunotherapy: the radiotherapy example

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Interstitial pneumonitis following total body irradiation for bone marrow transplantation using two different dose rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Clinical basis for TBI fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Long-term effects on bone mineral density of different therapeutic schemes for acute lymphoblastic leukemia or non-Hodgkin lymphoma during childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Late effects and quality of life of childhood cancer survivors: Part 2. Impact of radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Veno-occlusive disease of the liver after hemopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Solid cancers after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Solid cancers after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Development and characterization of a lung-protective method of bone marrow transplantation in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: risks and benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Total body irradiation using a modified standing technique: a single institution 7 year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Novel technique of craniospinal axis proton therapy with the spot-scanning system: avoidance of patching multiple fields and optimized ventral dose distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Radiolabeled antibodies for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

Implantation of functional erythropoietic elements following total-body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Circulating rat cells in lethally irradiated mice protected with rat bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for B

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

What does total body irradiation do in bone marrow transplants for leukemia?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Hyperfractionated total body irradiation for bone marrow transplantation. results in seventy leukemia patients with allogeneic transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Interstitial pneumonitis following autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Protective conditioning for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.280

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.280

1 reference

Dimensions Publication ID

23 August 2017

1050028564

0 references

1 reference